Xenon
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological disorders... Read moreXenon
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological disorders... Read more
News
Dec 18, 2025
Seeking Alpha
Xenon: Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout
Dec 04, 2025
Benzinga
Xenon: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 03, 2025
Benzinga
Xenon: Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
Nov 03, 2025
Seeking Alpha
Xenon: Xenon Pharma GAAP EPS of -$1.15 in-line
Aug 12, 2025
Zacks
Xenon: Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
Aug 12, 2025
Seeking Alpha
Xenon: Xenon targets NDA filing for azetukalner within 6 months of phase III readout while advancing late-stage neuropsychiatric programs
Aug 12, 2025
Seeking Alpha
Xenon: Xenon Pharmaceuticals: Pushing Azetukalner Towards Finish Line With Phase 3 2026 Data Release
Aug 04, 2025
Benzinga
Xenon: Xenon to Report Q2 2025 Financial Results on August 11, 2025
Jun 27, 2025
StreetInsider
Press Release: Xenon : Xenon Joins the Russell 3000 and Russell 2000 Indexes
Jun 03, 2025
Marketscreener
Xenon: Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Xenon Competitors
1
2
3
4
5
6
7
8
9
10